VEGFA and preeclampsia: sFlt-1 is a soluble receptor for the vascular endothelial growth factor (VEGF) that binds to Placental Growth factor (PlGF) and VEGF receptors, thereby blocking their angiogenic function in the maternal circulation, leading to early onset preeclampsia before 34 weeks of gestation [26].